Answer
Eptinezumab is an antibody that binds calcitonin gene-related peptide (CGRP), preventing CGRP receptor activation and the downstream physiological events linked to the initiation of migraine attacks.
Sources for this answer
- Vyepti 100 mg concentrate for solution for infusion (300 mg not marketed)Lundbeck Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked